Mobile

A clinical trial to test if the drug ertugliflozin is safe and effective when compared to glimepiride in patients with Type 2 Diabetes whose sugar levels are not well controlled by treatment with meta...

Mise à jour : Il y a 4 ans
Référence : EUCTR2013-003582-34

A clinical trial to test if the drug ertugliflozin is safe and effective when compared to glimepiride in patients with Type 2 Diabetes whose sugar levels are not well controlled by treatment with metaformin

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

In subjects with T2DM and inadequate glycemic control on metformin: 1. After 52 weeks, to assess the A1C-lowering efficacy of the addition of ertugliflozin 15 mg q.d. compared with the addition of glimepiride. 2. To assess the safety and tolerability of ertugliflozin.

Critère d'inclusion

  • Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metaformin

Liens